Search Results

There are 23468 results for: content related to: The impact of race on outcomes of autologous transplantation in patients with multiple myeloma

  1. Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: A single center study

    Cancer

    Volume 121, Issue 7, April 1, 2015, Pages: 1064–1070, Vishal Bhatnagar, Yin Wu, Olga G. Goloubeva, Kathleen T. Ruehle, Todd E. Milliron, Carolynn G. Harris, Aaron P. Rapoport, Saul Yanovich, Edward A. Sausville, Maria R. Baer and Ashraf Z. Badros

    Article first published online : 2 DEC 2014, DOI: 10.1002/cncr.29160

  2. You have free access to this content
    Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective

    European Journal of Haematology

    Volume 94, Issue 1, January 2015, Pages: 12–22, Kai Hübel, Javier de la Rubia, Nabih Azar and Paolo Corradini

    Article first published online : 25 MAY 2014, DOI: 10.1111/ejh.12362

  3. You have full text access to this OnlineOpen article
    Changing trends in prognostic factors for patients with multiple myeloma after autologous stem cell transplantation during the immunomodulator drug/proteasome inhibitor era

    Cancer Science

    Volume 106, Issue 2, February 2015, Pages: 179–185, Hiroyuki Takamatsu, Sumihisa Honda, Toshihiro Miyamoto, Kenji Yokoyama, Shotaro Hagiwara, Toshiro Ito, Naoto Tomita, Shinsuke Iida, Toshihiro Iwasaki, Hisashi Sakamaki, Ritsuro Suzuki and Kazutaka Sunami

    Article first published online : 6 FEB 2015, DOI: 10.1111/cas.12594

  4. The timing of autologous stem cell transplantation and the prognostic factors affecting the prognosis in children with relapsed hodgkin lymphoma

    Pediatric Transplantation

    Erman Ataş, Vural Kesik, Oğuzhan Babacan, Nadir Korkmazer and Canan Akyüz

    Article first published online : 6 MAR 2015, DOI: 10.1111/petr.12449

  5. You have free access to this content
    Multiple myeloma: chemotherapy or transplantation in the era of new drugs

    European Journal of Haematology

    Volume 84, Issue 5, May 2010, Pages: 379–390, Antonio Palumbo and S. Vincent Rajkumar

    Article first published online : 23 MAR 2010, DOI: 10.1111/j.1600-0609.2010.01431.x

  6. You have free access to this content
    Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group

    Internal Medicine Journal

    Volume 45, Issue 1, January 2015, Pages: 94–105, H. Quach, D. Joshua, J. Ho, J. Szer, A. Spencer, S. J. Harrison, P. Mollee, A. W. Roberts, N. Horvath, D. Talulikar, B. To, A. Zannettino, R. Brown, L. Catley, B. Augustson, W. Jaksic, J. Gibson and H. M. Prince

    Article first published online : 12 JAN 2015, DOI: 10.1111/imj.12640

  7. Evaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single-institution study

    Transplant Infectious Disease

    Volume 16, Issue 6, December 2014, Pages: 1032–1038, F. Marchesi, F. Pimpinelli, M.L. Dessanti, S. Gumenyuk, F. Palombi, F. Pisani, A. Romano, A. Spadea, M. Maschio, F. Ensoli and A. Mengarelli

    Article first published online : 5 NOV 2014, DOI: 10.1111/tid.12309

  8. Autologous stem cell transplantation in diffuse scleroderma: impact on hand structure and function

    Internal Medicine Journal

    Volume 38, Issue 9, September 2008, Pages: 692–696, H. Englert, 1 S. Kirkham, 2 J. Moore, 3 T. S. Poon, 4 C. Katelaris, 5 N. McGill, 6 L. Schrieber and 7 N. Manolios 1

    Article first published online : 11 MAR 2008, DOI: 10.1111/j.1445-5994.2007.01593.x

  9. 131I-MIBG followed by consolidation with busulfan, melphalan and autologous stem cell transplantation for refractory neuroblastoma

    Pediatric Blood & Cancer

    Volume 60, Issue 5, May 2013, Pages: 879–884, Sarah French, Steven G. DuBois, Biljana Horn, Meaghan Granger, Randall Hawkins, Amy Pass, Ellen Plummer and Katherine Matthay

    Article first published online : 28 SEP 2012, DOI: 10.1002/pbc.24351

  10. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients

    Internal Medicine Journal

    Volume 44, Issue 8, August 2014, Pages: 771–778, J. Lewin, M. Dickinson, M. Voskoboynik, M. Collins, D. Ritchie and G. Toner

    Article first published online : 1 AUG 2014, DOI: 10.1111/imj.12486

  11. Haematopoietic stem cell transplantation for treatment of primary CNS lymphoma: single-centre experience and literature review

    European Journal of Haematology

    Marija Bojic, Anna S. Berghoff, Marlene Troch, Hermine Agis, Wolfgang R. Sperr, Georg Widhalm, Adelheid Wöhrer, Peter Kalhs, Matthias Preusser and Werner Rabitsch

    Article first published online : 23 MAR 2015, DOI: 10.1111/ejh.12482

  12. You have free access to this content
    Axial summit trough of the East Pacific Rice 9°–10°N: Geological characteristics and evolution of the axial zone on fast spreading mid-ocean ridge

    Journal of Geophysical Research: Solid Earth (1978–2012)

    Volume 103, Issue B5, 10 May 1998, Pages: 9827–9855, Daniel J. Fornari, Rachel M. Haymon, Michael R. Perfit, Tracy K. P. Gregg, Margo H. Edwards

    Article first published online : 20 SEP 2012, DOI: 10.1029/98JB00028

  13. Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: Results of German trials

    Pediatric Blood & Cancer

    Volume 56, Issue 4, April 2011, Pages: 578–583, Thorsten Simon, Frank Berthold, Arndt Borkhardt, Bernhard Kremens, Boris De Carolis and Barbara Hero

    Article first published online : 9 DEC 2010, DOI: 10.1002/pbc.22693

  14. Two cycles of the PS-341/bortezomib, adriamycin, and dexamethasone combination followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients

    European Journal of Haematology

    Volume 88, Issue 6, June 2012, Pages: 478–484, Jung-Hee Lee, Je-Hwan Lee, Dae-Young Kim, Sung-Doo Kim, Yunsuk Choi, Young-Ah Kang, Miee Seol and Kyoo-Hyung Lee

    Article first published online : 11 APR 2012, DOI: 10.1111/j.1600-0609.2012.01771.x

  15. Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma

    Transfusion

    Volume 49, Issue 9, September 2009, Pages: 1890–1900, Dok Hyun Yoon, Byeong Seok Sohn, Geundoo Jang, Eun Kyoung Kim, Byung Woog Kang, Chul Kim, Jeong-Eun Kim, Shin Kim, Dae Ho Lee, Jung-Shin Lee, Seo-Jin Park, Chan-Jeoung Park, Jooryung Huh and Cheolwon Suh

    Article first published online : 11 MAY 2009, DOI: 10.1111/j.1537-2995.2009.02202.x

  16. You have free access to this content
    A randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma

    Cancer

    Volume 118, Issue 19, 1 October 2012, Pages: 4706–4714, Avichai Shimoni, Irit Avivi, Jacob M. Rowe, Moshe Yeshurun, Itai Levi, Reuven Or, Paulina Patachenko, Abraham Avigdor, Tzila Zwas and Arnon Nagler

    Article first published online : 17 JAN 2012, DOI: 10.1002/cncr.27418

  17. You have free access to this content
    High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma

    Intervention Review

    The Cochrane Library

    Michaela Rancea, Ina Monsef, Bastian von Tresckow, Andreas Engert and Nicole Skoetz

    Published Online : 20 JUN 2013, DOI: 10.1002/14651858.CD009411.pub2

  18. You have free access to this content
    Guidelines on the management of AL amyloidosis

    British Journal of Haematology

    Volume 168, Issue 2, January 2015, Pages: 186–206, Ashutosh D. Wechalekar, Julian D. Gillmore, Jenny Bird, Jamie Cavenagh, Stephen Hawkins, Majid Kazmi, Helen J. Lachmann, Philip N. Hawkins, Guy Pratt and on behalf ofthe BCSH Committee

    Article first published online : 9 OCT 2014, DOI: 10.1111/bjh.13155

  19. Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma

    Cancer

    Volume 121, Issue 2, 15 January 2015, Pages: 226–233, Yi-Bin Chen, Tracy Batchelor, Shuli Li, Ephraim Hochberg, Mark Brezina, Sooae Jones, Candice Del Rio, Morgan Curtis, Karen K. Ballen, Jeffrey Barnes, Andrew S. Chi, Jorg Dietrich, Jessica Driscoll, Elizabeth R. Gertsner, Fred Hochberg, Ann S. LaCasce, Steven L. McAfee, Thomas R. Spitzer, Lakshmi Nayak and Philippe Armand

    Article first published online : 9 SEP 2014, DOI: 10.1002/cncr.29023

  20. Zevalin and BEAM (Z-BEAM) versus rituximab and BEAM (R-BEAM) conditioning chemotherapy prior to autologous stem cell transplantation in patients with mantle cell lymphoma

    Hematological Oncology

    Martin D. Berger, Giacomo Branger, Bernd Klaeser, Behrouz Mansouri Taleghani, Urban Novak, Yara Banz, Beatrice U. Mueller and Thomas Pabst

    Article first published online : 17 FEB 2015, DOI: 10.1002/hon.2197